Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma: A Randomized, Open-label, Controlled, Multicenter Phase II Trial

NCT07362979 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT07362979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07362979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma: A Randomized, Open-label, Controlled, Multicenter Phase II Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Recruiting
Start date
March 12, 2026
Completion date
March 12, 2031
Enrollment
243 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal cancinoma (npc)